Back
Plus Therapeutics Stock Price Chart

This tech company grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
29
PSTV
Plus Therapeutics
Last Price:
$0.78
Seasonality Move:
-5.47%
7 Day Trial
ALL ACCESS PASS
$
7

Major Market Shift - Act Now Before it's Too Late
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PSTV is experiencing slight selling pressure.
Plus Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.75 | Buy |
20-day SMA: | 0.81 | Sell |
50-day SMA: | 0.94 | Sell |
200-day SMA: | 1.28 | Sell |
8-day EMA: | 0.79 | Sell |
20-day EMA: | 0.83 | Sell |
50-day EMA: | 0.94 | Sell |
200-day EMA: | 1.29 | Sell |
Plus Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 47.37 | Sell |
Chaikin Money Flow: | -375445 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.66 - 1.18) | Sell |
Bollinger Bands (100): | (0.81 - 1.35) | Sell |
Plus Therapeutics Technical Analysis
Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Plus Therapeutics Stock
Is Plus Therapeutics Stock a Buy?
-
Plus Therapeutics share price is 0.79 while PSTV 8-day simple moving average is 0.75, which is a Buy signal.
-
The stock price of PSTV is 0.79 while Plus Therapeutics 20-day SMA is 0.81, which makes it a Sell.
-
Plus Therapeutics 50-day simple moving average is 0.94 while PSTV share price is 0.79, making it a Sell technically.
-
PSTV stock price is 0.79 and Plus Therapeutics 200-day simple moving average is 1.28, creating a Sell signal.
PSTV Technical Analysis vs Fundamental Analysis
Sell
29
Plus Therapeutics (PSTV)
is a Sell
Is Plus Therapeutics a Buy or a Sell?
-
Plus Therapeutics stock is rated a SellThe current Plus Therapeutics [PSTV] share price is $0.79. The Score for PSTV is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
Plus Therapeutics Stock Info
Market Cap:
13.4M
Price in USD:
0.79
Share Volume:
932.4K
Plus Therapeutics 52-Week Range
52-Week High:
2.67
52-Week Low:
0.24
Sell
29
Plus Therapeutics (PSTV)
is a Sell
Plus Therapeutics Share Price Forecast
-
What is the Plus Therapeutics stock price today?The Plus Therapeutics stock price is 0.79 USD today.
-
Will PSTV stock go up or go down?Plus Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Plus Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Plus Therapeutics is overvalued.
Is Plus Therapeutics Stock a Buy?
-
Plus Therapeutics share price is 0.79 while PSTV 8-day exponential moving average is 0.79, which is a Sell signal.
-
The stock price of PSTV is 0.79 while Plus Therapeutics 20-day EMA is 0.83, which makes it a Sell.
-
Plus Therapeutics 50-day exponential moving average is 0.94 while PSTV share price is 0.79, making it a Sell technically.
-
PSTV stock price is 0.79 and Plus Therapeutics 200-day simple moving average is 1.29, creating a Sell signal.
Fundamental Analysis of Plus Therapeutics
Is Plus Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.30 per share, an increase next quarter of $0.03 per share, an increase this year of $1.10 per share, and an increase next year of $0.08 per share.
Technical Analysis of Plus Therapeutics
Should I short Plus Therapeutics stock?
-
PSTV Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting Plus Therapeutics is a Sell
-
Plus Therapeutics Relative Strength Index (RSI) is 47.37, which suggest Plus Therapeutics is oversold
-
The Bollinger Bands (25) for Plus Therapeutics is (0.66 - 1.18), which suggest Plus Therapeutics is a Sell
-
The Bollinger Bands (100) for Plus Therapeutics is (0.81 - 1.35), which suggest Plus Therapeutics is a Sell
* Plus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.